PHARMASUST 500 - Pharmacom Labs

The Organon company launched Sustanon around the 1970s, a blend containing four esters: propionate, phenylpropionate, isocaproate, and decanoate. Each one metabolizes at different rates, offering an immediate testosterone boost followed by a prolonged release. This structure was aimed at reducing the frequency of injections making it a popular choice for hormone replacement therapy. Although it never achieved FDA approval but still has been widely used internationally for maintaining steady testosterone levels in men having androgen deficiencies.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about PHARMASUST 500 by Pharmacom Labs, consult with your doctor or healthcare professional.